Cargando…

Salvaging hope: Is increasing NAD(+) a key to treating mitochondrial myopathy?

Mitochondrial diseases can arise from mutations either in mitochondrial DNA or in nuclear DNA encoding mitochondrially destined proteins. Currently, there is no cure for these diseases although treatments to ameliorate a subset of the symptoms are being developed. In this issue of EMBO Molecular Med...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lightowlers, Robert N, Chrzanowska-Lightowlers, Zofia MA
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2014
Materias:	Closeup
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4203349/ https://www.ncbi.nlm.nih.gov/pubmed/24838280 http://dx.doi.org/10.15252/emmm.201404179

Ejemplares similares

Could successful (mitochondrial) networking help prevent Huntington's disease?
por: Oliveira, Jorge M A, et al.
Publicado: (2010)

How much does a disrupted mitochondrial network influence neuronal dysfunction?
por: Chrzanowska‐Lightowlers, Zofia MA, et al.
Publicado: (2018)

Mitochondrial transplantation—a possible therapeutic for mitochondrial dysfunction?: Mitochondrial transfer is a potential cure for many diseases but proof of efficacy and safety is still lacking
por: Lightowlers, Robert N, et al.
Publicado: (2020)

Human mitochondrial nucleases
por: Bruni, Francesco, et al.
Publicado: (2017)

Mitochondrial protein synthesis: Figuring the fundamentals, complexities and complications, of mammalian mitochondrial translation
por: Lightowlers, Robert N., et al.
Publicado: (2014)

Mixing and matching mitochondrial aminoacyl synthetases and their tRNAs: a new way to treat respiratory chain disorders?
por: Tyynismaa, Henna, et al.
Publicado: (2014)

The process of mammalian mitochondrial protein synthesis
por: Mai, Nicole, et al.
Publicado: (2016)

In a flurry of PINK, mitochondrial bioenergetics takes a leading role in Parkinson's disease
por: Murphy, Anne N
Publicado: (2009)

Human pentatricopeptide proteins: Only a few and what do they do?
por: Lightowlers, Robert N, et al.
Publicado: (2013)

A magic bullet to specifically eliminate mutated mitochondrial genomes from patients' cells
por: Moraes, Carlos T
Publicado: (2014)

Making the most of what you've got: Optimizing residual OXPHOS function in mitochondrial diseases
por: Moraes, Carlos T
Publicado: (2009)

Human mitochondrial mRNAs—like members of all families, similar but different
por: Temperley, Richard J., et al.
Publicado: (2010)

Human ERAL1 is a mitochondrial RNA chaperone involved in the assembly of the 28S small mitochondrial ribosomal subunit
por: Dennerlein, Sven, et al.
Publicado: (2010)

AMPed up to treat prostate cancer: novel AMPK activators emerge for cancer therapy
por: Schiewer, Matthew J, et al.
Publicado: (2014)

Targeting protein–protein interactions to rescue Δf508-cftr: a novel corrector approach to treat cystic fibrosis
por: Devesa, Isabel, et al.
Publicado: (2013)

Response to “Ribosome Rescue and Translation Termination at Non-standard Stop Codons by ICT1 in Mammalian Mitochondria”
por: Chrzanowska-Lightowlers, Zofia Maria, et al.
Publicado: (2015)

Targeting of the cytosolic poly(A) binding protein PABPC1 to mitochondria causes mitochondrial translation inhibition
por: Wydro, Mateusz, et al.
Publicado: (2010)

High mobility group box-1 recognition: The beginning of a RAGEless era?
por: Branco-Madeira, Filipe, et al.
Publicado: (2010)

Divide and conquer: the genetic basis of molecular subclassification of breast cancer
por: Kristensen, Vessela N
Publicado: (2011)

Human mitochondrial ribosomes can switch structural tRNAs – but when and why?
por: Chrzanowska-Lightowlers, Zofia, et al.
Publicado: (2017)

Selecting for predisposition to cancer cachexia
por: Gioulbasanis, Ioannis, et al.
Publicado: (2012)

The heart-liver metabolic axis: defective communication exacerbates disease
por: Baskin, Kedryn K, et al.
Publicado: (2014)

High-resolution imaging reveals compartmentalization of mitochondrial protein synthesis in cultured human cells
por: Zorkau, Matthew, et al.
Publicado: (2021)

A surrogate marker for Aβ42 production in the CNS
por: Holtzman, David M
Publicado: (2009)

Through a glass darkly
por: Hall, James E
Publicado: (2012)

Decoding the evolution of a breast cancer genome
por: Bedard, Philippe L, et al.
Publicado: (2010)

Suppressing nonsense—a surprising function for 5-azacytidine
por: Shao, Ada, et al.
Publicado: (2014)

A new inducible model for t(8;21) AML
por: Mulloy, James C
Publicado: (2013)

Back to the future: a new ‘old’ lead for tuberculosis
por: Wright, Gerard D
Publicado: (2012)

VEGF-B: a more balanced approach toward cardiac neovascularization?
por: Kupatt, Christian, et al.
Publicado: (2014)

Prion protein in Alzheimer's pathogenesis: a hot and controversial issue
por: Benilova, Iryna, et al.
Publicado: (2010)

Interferon-lambda as a new approach for treatment of allergic asthma?
por: Edwards, Michael R, et al.
Publicado: (2011)

Telomerase gene therapy: a novel approach to combat aging
por: Boccardi, Virginia, et al.
Publicado: (2012)

A new way APP mismetabolism can lead to Alzheimer's disease
por: Hardy, John, et al.
Publicado: (2011)

VEGF sticky-trap: the first report of a non-systemically acting angiogenesis inhibitor
por: Favara, David M, et al.
Publicado: (2014)

Déjà vu with a twist: transglutaminases in bioenergetics and transcriptional dysfunction in Huntington's disease
por: Kazemi-Esfarjani, Parsa, et al.
Publicado: (2010)

GLI1 finds a new role in cancer stem cell biology
por: Fernandez-Zapico, Martin E
Publicado: (2013)

Farber disease: understanding a fatal childhood disorder and dissecting ceramide biology
por: Sands, Mark S
Publicado: (2013)

Asthma exacerbations: a molecular dichotomy between antiviral and pro-inflammatory responses revealed
por: Andreakos, Evangelos
Publicado: (2012)

PI3K signaling in the locus coeruleus: a new molecular pathway for ADHD research
por: Darcq, Emmanuel, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_qcja9u5c9f4q9cern4714ou1sr